￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Which patients with lung cancer are mainly suitable for capmatinib?

2026-02-01 22:25:32

Check Details
Safety and dosage adjustment of larotinib/larlotinib in elderly patients

2026-02-01 22:25:32

Check Details
What information does the manufacturer of Seleniso include?

2026-02-01 22:25:32

Check Details
Where to get the drug instructions for Elacetrant

2026-02-01 22:25:32

Check Details
How effective is reflimab? Objective response rate and survival data

2026-02-01 22:25:32

Check Details
Indications and treatment scope of related diseases of icorituzumab

2026-02-01 22:25:32

Check Details
What diseases is Gefituzumab mainly used to treat?

2026-02-01 22:25:32

Check Details
Interval duration of roselixizumab treatment for myasthenia gravis

2026-02-01 22:25:32

Check Details
What is the latest market price of Elacetrant in 2025?

2026-02-01 22:25:32

Check Details
Usage and dosage of Riflimab: Instructions on injection frequency and treatment duration

2026-02-01 22:25:32

Check Details
Which company developed Ikorituzumab?

2026-02-01 22:25:32

Check Details
What is the therapeutic effect of 6 courses of gaffetuzumab?

2026-02-01 22:25:32

Check Details
Category
相关知识